6:05 PM
 | 
Feb 21, 2013
 |  BC Extra  |  Financial News

Immunomedics proposes follow-on

Immunomedics Inc. (NASDAQ:IMMU) said late Thursday it is planning a follow-on underwritten by Oppenheimer and Cowen. Immunomedics'

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >